Literature DB >> 25172638

Evaluation of two chromogenic media for the isolation and identification of urinary tract pathogens.

M Payne1, D Roscoe.   

Abstract

Chromogenic media (CM) are available for urine specimens (US) to enable rapid identification of common urinary tract pathogens (UTP). Two CM, chromID™ CPS (CPS4) agar (bioMérieux, St. Laurent, QC) and UriSelect™ 4 (URS4) agar (Bio-Rad, Montreal, QC), were compared to the standard media (SM) for the isolation and identification of UTP. Over a 10-day period, US were inoculated to CPS4, URS4, and SM (BAP and MAC). CM interpretation was done according to the product inserts by one person blinded to the results of SM. SM were read by experienced technologists according to protocol and isolates were identified using BD Phoenix™. The results were grouped into significant (SG), mixed (MG), and no significant growth (NSG). A total of 903 US were studied. SM identified 239 SG, 112 MG, and 552 NSG cultures. The most common pathogens were Escherichia coli (38 %) and Enterococcus spp. (11 %). Comparing CM to SM, the exact agreement was 89.3 and 89.5 % for URS4 and CPS4, respectively. When grouped by clinical significance, agreement with SM was 93.0 and 93.1 % for URS4 and CPS4, respectively. CM were equivalent with respect to processing time. Advantages include decreased need for automated identification of certain species, particularly E. coli. In terms of workflow, CM enables same-day identification for almost 50 % of significant UTP. Overall, both CM compared well to SM and allowed for rapid preliminary identification of many UTP.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25172638     DOI: 10.1007/s10096-014-2235-3

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  21 in total

1.  Performance of four chromogenic urine culture media after one or two days of incubation compared with reference media.

Authors:  Olle Aspevall; Björn Osterman; Rakel Dittmer; Lena Stén; Emma Lindbäck; Urban Forsum
Journal:  J Clin Microbiol       Date:  2002-04       Impact factor: 5.948

2.  Comparative evaluation of two commercial chromogenic media for detection and presumptive identification of urinary tract pathogens.

Authors:  C Scarparo; P Piccoli; P Ricordi; M Scagnelli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-04-10       Impact factor: 3.267

3.  Practical bench comparison of BBL CHROMagar Orientation and standard two-plate media for urine cultures.

Authors:  Holly A D'Souza; Mary Campbell; Ellen Jo Baron
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

4.  A comparison of the performance of commercially available chromogenic agars for the isolation and presumptive identification of organisms from urine.

Authors:  D Fallon; G Ackland; N Andrews; D Frodsham; S Howe; K Howells; K J Nye; R E Warren
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

5.  Evaluation of three commercial agar preparations for the presumptive identification of significant urinary isolates.

Authors:  K I Miles; M W D Wren
Journal:  Br J Biomed Sci       Date:  2005       Impact factor: 3.829

6.  Evaluation of BBL CHROMagar orientation medium for detection and presumptive identification of urinary tract pathogens.

Authors:  K A Hengstler; R Hammann; A M Fahr
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

7.  Comparative evaluation of Vitek 2 identification and susceptibility testing of urinary tract pathogens directly and isolated from chromogenic media.

Authors:  M J Munoz-Dávila; M Roig; G Yagüe; A Blázquez; C Salvador; M Segovia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-12       Impact factor: 3.267

8.  Evaluation of CHROMagar Orientation for differentiation and presumptive identification of gram-negative bacilli and Enterococcus species.

Authors:  J Merlino; S Siarakas; G J Robertson; G R Funnell; T Gottlieb; R Bradbury
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

9.  Rapid identification of Enterobacteriaceae. II. Use of a beta-glucuronidase detecting agar medium (PGUA agar) for the identification of E. coli in primary cultures of urine samples.

Authors:  M Kilian; P Bülow
Journal:  Acta Pathol Microbiol Scand B       Date:  1979-10

10.  Comparison of three chromogenic agar plates for isolation and identification of urinary tract pathogens.

Authors:  C Chaux; M Crepy; S Xueref; C Roure; Y Gille; A M Freydiere
Journal:  Clin Microbiol Infect       Date:  2002-10       Impact factor: 8.067

View more
  5 in total

1.  Evaluation of New bioMérieux Chromogenic CPS Media for Detection of Urinary Tract Pathogens.

Authors:  Josselin Rigaill; Paul O Verhoeven; Caroline Mahinc; Mohamed Jeraiby; Florence Grattard; Nathalie Fonsale; Bruno Pozzetto; Anne Carricajo
Journal:  J Clin Microbiol       Date:  2015-05-20       Impact factor: 5.948

Review 2.  A Decade of Development of Chromogenic Culture Media for Clinical Microbiology in an Era of Molecular Diagnostics.

Authors:  John D Perry
Journal:  Clin Microbiol Rev       Date:  2017-04       Impact factor: 26.132

3.  Culture of Urine Specimens by Use of chromID CPS Elite Medium Can Expedite Escherichia coli Identification and Reduce Hands-On Time in the Clinical Laboratory.

Authors:  Melanie L Yarbrough; Meghan A Wallace; Cynthia Marshall; Erin Mathias; C A Burnham
Journal:  J Clin Microbiol       Date:  2016-08-31       Impact factor: 5.948

4.  Evaluation of Providencia rettgeri pathogenicity against laboratory Mediterranean fruit fly strain (Ceratitis capitata).

Authors:  Meriem Msaad Guerfali; Wafa Djobbi; Kamel Charaabi; Heithem Hamden; Salma Fadhl; Wafa Marzouki; Ferjani Dhaouedi; Claude Chevrier
Journal:  PLoS One       Date:  2018-05-07       Impact factor: 3.240

5.  Optical scatter patterns facilitate rapid differentiation of Enterobacteriaceae on CHROMagar™ Orientation medium.

Authors:  Atul K Singh; Arun K Bhunia
Journal:  Microb Biotechnol       Date:  2015-10-27       Impact factor: 5.813

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.